Operating Room Air Filtration/Sterilization
- Conditions
- Surgery
- Interventions
- Device: Functioning Aerus air filtration/sterilizationDevice: Deactivated Aerus air filtration/sterilization
- Registration Number
- NCT04610294
- Lead Sponsor
- The Cleveland Clinic
- Brief Summary
Determine whether operating room air filtration and sterilization with the ActivePure system reduces a composite of serious surgical site infections, infection-related complications, and death within 30 days after surgery.
- Detailed Description
The investigators primary goal is thus to determine whether supplemental filtering and sterilizing operating room air reduces a composite of serious surgical site infections, infection-related complications, and death within 30 days after surgery. The primary outcome will be restricted to inpatients. However, outpatients will be simultaneously enrolled given the trial's cluster design. Sample-size is based on our primary inpatient analysis, N= 66,273 inpatients. Available outpatients will be included for analysis of our secondary outcome which includes both inpatients and outpatients.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 66273
- All patients in designated adult operating rooms
- American Society of Anesthesiologists physical status 1-4.
- Surgery lasting at least 1 hour.
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Aerus air sterilization Functioning Aerus air filtration/sterilization Aerus air sterilization system will be used in an operating room, in addition to routine room air filtration Conventional air handling Deactivated Aerus air filtration/sterilization Only routine room air filtration will be used in an operation room.
- Primary Outcome Measures
Name Time Method Serious surgical site infections and related complication in previously uninfected surgical inpatients 30 days after surgery Composite of serious surgical site infections, infection-related complications, and death in surgical inpatients without present-on-admission composite infection components
- Secondary Outcome Measures
Name Time Method Serious surgical site infections and related complication in previously uninfected surgical inpatients and outpatients 30 days after surgery Composite of serious surgical site infections, infection-related complications, and death in surgical inpatients and outpatients without present-on-admission composite infection components
Trial Locations
- Locations (1)
Cleveland Clinic
🇺🇸Cleveland, Ohio, United States